Slovakian sprinter Ľuboš Križko has been banned for two years by FINA, after testing positive for a metabolite of Tamoxifen at the European championships in Budapest on August 12, 2010. Tamoxifen is the standard anti-estrogen therapy used to treat breast cancer patients, but is also used in doping to control the side effects of taking steroids. Read SwimNews.com.
Previous ArticleThis is why they call them Killer Whales
Next Article Will Shanghai 2011 be a doping risk for athletes?